Actuate Therapeutics IncACTUNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+73.1%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+73.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
5.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$245979.00+111.6%
2024$-2.12M-1026.6%
2023$229209.00+383.5%
2022$47406.00-